Sign in to view content

Noninferiority of 1.7% Povidone–Iodine for Endophthalmitis Prophylaxis After Intravitreal Injections Compared With 5% Povidone–Iodine in an Office Setting

Kamal Kishore, MD, MBBS

Video
Published 2022

Related

Cognitive Testing in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
Subhransu K. Ray, MD, PhD
Annual Meeting Talks
2020
Outcomes of Rhegmatogenous Retinal Detachment Repair Following Infectious Endophthalmitis
Frances Wu, MD
Annual Meeting Talks
2021
New Treatment Paradigm for Infectious Endophthalmitis: Results From the Mexican Endophthalmitis Study Group Protocol 1 and 3
Raul Velez-Montoya, MD
Annual Meeting Talks
2024

Category: Pharmacology

See more